135 related articles for article (PubMed ID: 2459520)
21. Lasting changes in high affinity 3H-spiperone binding to the rat striatum and mesolimbic area after chronic methamphetamine administration: evaluation of dopaminergic and serotonergic receptor components.
Akiyama K; Sato M; Kashihara K; Otsuki S
Biol Psychiatry; 1982 Dec; 17(12):1389-402. PubMed ID: 7159638
[TBL] [Abstract][Full Text] [Related]
22. Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes.
Hamblin MW; Leff SE; Creese I
Biochem Pharmacol; 1984 Mar; 33(6):877-87. PubMed ID: 6712712
[TBL] [Abstract][Full Text] [Related]
23. The effect of GYKI-32 887 on dopamine (D2) and serotonin (5-HT1 and 5-HT2) receptors.
Berzétei IP; Bagdy E; Hardy M; Borsy J
Pol J Pharmacol Pharm; 1985; 37(3):237-42. PubMed ID: 4070077
[TBL] [Abstract][Full Text] [Related]
24. Autoradiographic localization of dopamine DA-2 receptor sites in rat mesenteric vascular tree.
Ricci A; Amenta F
J Pharmacol Exp Ther; 1990 Aug; 254(2):750-5. PubMed ID: 2143538
[TBL] [Abstract][Full Text] [Related]
25. Phenoxybenzamine treatment differentiates dopaminergic 3H-ligand binding sites in bovine caudate membranes.
Hamblin MW; Creese I
Mol Pharmacol; 1982 Jan; 21(1):44-51. PubMed ID: 6127621
[TBL] [Abstract][Full Text] [Related]
26. Evidence for the existence of receptor--receptor interactions in the central nervous system. Studies on the regulation of monoamine receptors by neuropeptides.
Fuxe K; Agnati LF; Benfenati F; Celani M; Zini I; Zoli M; Mutt V
J Neural Transm Suppl; 1983; 18():165-79. PubMed ID: 6192208
[TBL] [Abstract][Full Text] [Related]
27. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
[TBL] [Abstract][Full Text] [Related]
28. A quantitative method of analyzing the interaction of slightly selective radioligands with multiple receptor subtypes.
McGonigle P; Neve KA; Molinoff PB
Mol Pharmacol; 1986 Oct; 30(4):329-37. PubMed ID: 2876374
[TBL] [Abstract][Full Text] [Related]
29. Regulation of serotonin2 (5-HT2) receptors labeled with [3H]spiroperidol by chronic treatment with the antidepressant amitriptyline.
Peroutka SJ; Snyder SH
J Pharmacol Exp Ther; 1980 Dec; 215(3):582-7. PubMed ID: 6255132
[TBL] [Abstract][Full Text] [Related]
30. [3H]dihydroergotamine as a high-affinity, slowly dissociating radioligand for 5-HT1B binding sites in rat brain membranes: evidence for guanine nucleotide regulation of agonist affinity states.
Hamblin MW; Ariani K; Adriaenssens PI; Ciaranello RD
J Pharmacol Exp Ther; 1987 Dec; 243(3):989-1001. PubMed ID: 2826763
[TBL] [Abstract][Full Text] [Related]
31. Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia.
Joyce JN; Lexow N; Bird E; Winokur A
Synapse; 1988; 2(5):546-57. PubMed ID: 2973147
[TBL] [Abstract][Full Text] [Related]
32. Regulation of dopamine D2 receptors by sodium and pH.
Neve KA
Mol Pharmacol; 1991 Apr; 39(4):570-8. PubMed ID: 2017157
[TBL] [Abstract][Full Text] [Related]
33. Classification of serotonin receptors.
Göthert M; Schlicker E
J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S3-7. PubMed ID: 2446065
[TBL] [Abstract][Full Text] [Related]
34. Labelling of D2-dopaminergic and 5-HT2-serotonergic binding sites in human trophoblastic cells using [3H]-spiperone.
Vaillancourt C; Petit A; Gallo-Payet N; Bellabarba D; Lehoux JG; Bélisle S
J Recept Res; 1994 Jan; 14(1):11-22. PubMed ID: 8158579
[TBL] [Abstract][Full Text] [Related]
35. Properties of D2 dopamine receptor autoradiography: high percentage of high-affinity agonist sites and increased nucleotide sensitivity in tissue sections.
Richfield EK; Young AB; Penney JB
Brain Res; 1986 Sep; 383(1-2):121-8. PubMed ID: 3768686
[TBL] [Abstract][Full Text] [Related]
36. Differential affinities of molindone, metoclopramide and domperidone for classes of [3H]spiroperidol binding sites in rat striatum: evidence for pharmacologically distinct classes of receptors.
Rosenfeld MR; Dvorkin B; Klein PN; Makman MH
Brain Res; 1982 Mar; 235(1):205-11. PubMed ID: 6145486
[TBL] [Abstract][Full Text] [Related]
37. In vitro and in vivo binding of (E)- and (Z)-N-(iodoallyl)spiperone to dopamine D2 and serotonin 5-HT2 neuroreceptors.
Lever JR; Scheffel UA; Stathis M; Musachio JL; Wagner HN
Life Sci; 1990; 46(26):1967-76. PubMed ID: 2362552
[TBL] [Abstract][Full Text] [Related]
38. Evidence for the presence of D2 and 5-HT2 receptors in the human prefrontal cortex.
Mita T; Kuno T; Nakai H; Tanaka C
Jpn J Pharmacol; 1982 Dec; 32(6):1027-32. PubMed ID: 7161958
[TBL] [Abstract][Full Text] [Related]
39. Distinct target size of dopamine D-1 and D-2 receptors in rat striatum.
Nielsen M; Klimek V; Hyttel J
Life Sci; 1984 Jul; 35(3):325-32. PubMed ID: 6235424
[TBL] [Abstract][Full Text] [Related]
40. Postnatal ontogeny of dopamine D2 receptors in rat striatum.
Murrin LC; Zeng W
Biochem Pharmacol; 1986 Apr; 35(7):1159-62. PubMed ID: 2938588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
